Did you know there are tests that can help determine your course of treatment — and also save you from unnecessary treatment?! The Oncotype DX Breast Cancer Assay test predicts the best treatment for invasive breast cancers and the risk of distant recurrence, and the Oncotype DX DCIS predicts the risk of local recurrence.
One in five women who are diagnosed with breast cancer are diagnosed with DCIS (Ductal Carcinoma In-Situ)— also referred to as stage 0 breast cancer. It’s an early, non-invasive form of breast cancer where cancer cells are found only within milk ducts in the breasts.
Watch the video to learn more about the Oncotype DX DCIS test. It’s fascinating!Whizzco